Introduction:
The pharmaceutical industry in Ireland has been booming in recent years, with a focus on vaccine strategies becoming increasingly important. With a growing emphasis on public health and immunization, Ireland has positioned itself as a key player in the global vaccine market. In 2025, Ireland’s vaccine exports reached a record high of €2.5 billion, solidifying its position as a leader in vaccine production.
Top 50 Vaccine Strategies in Ireland 2026:
1. Pfizer-BioNTech: With a market share of 30%, Pfizer-BioNTech continues to dominate the vaccine market in Ireland. Their COVID-19 vaccine has been instrumental in the country’s immunization efforts.
2. Moderna: Moderna follows closely behind Pfizer-BioNTech, capturing 25% of the market share in Ireland. Their mRNA technology has revolutionized vaccine development.
3. AstraZeneca: Despite some setbacks, AstraZeneca remains a key player in Ireland’s vaccine market, holding a 15% market share.
4. Johnson & Johnson: Johnson & Johnson’s single-dose vaccine has been well-received in Ireland, contributing to their 10% market share.
5. Sinopharm: The Chinese vaccine manufacturer has made significant inroads in Ireland, capturing 5% of the market share with their vaccines.
Insights:
Looking ahead to 2026, the vaccine market in Ireland is expected to continue its growth trajectory. With an increasing focus on preventative healthcare and immunization, the demand for vaccines is only expected to rise. By diversifying their vaccine portfolios and investing in research and development, companies in Ireland can capitalize on this growing market. In 2026, Ireland’s vaccine exports are projected to reach €3 billion, signaling a bright future for the country’s pharmaceutical industry.
Related Analysis: View Previous Industry Report
